非小细胞肺癌袖状肺叶切除术:预测可切除性的CT特征与结局分析
本研究纳入45例计划以袖状肺叶切除术(SL)为首选术式的非小细胞肺癌患者,分析预测SL无残留病变可切除性的CT特征及结局。 salvage支气管肿瘤累及长度≤5 mm是SL无残留病变可切除性的唯一显著预测因素(OR 16.0,95%CI 3.7-69.6,P<0.001),AUC为0.802。SL无残留病变组生存似更优(P=0.110),但术后并发症率两组相似(20.0% vs 25.0%)。
要点
- salvage支气管肿瘤累及长度≤5 mm预测SL无残留病变可切除,OR 16.0(95%CI 3.7-69.6,P<0.001)。
- 该CT特征的AUC为0.802,5 mm为最佳截断值。
- SL无残留病变组生存似优于残留病变或全肺切除组(P=0.110),并发症率相似。
核心结论
- salvage支气管肿瘤累及长度≤5 mm是预测SL无残留病变可切除性的CT特征,可能改善NSCLC患者生存。
研究设计与样本
- 研究纳入45例计划以SL为首选术式并于2014年2月至2017年7月接受SL或全肺切除术的NSCLC患者,按SL是否无残留病变二分,采用ROC曲线和logistic回归分析预测可切除性的CT特征,并比较两组术后并发症和生存。
关键影像表现/征象
- salvage支气管(SL中代表远端吻合端)肿瘤累及长度≤5 mm与SL无残留病变可切除性相关,AUC为0.802。
- SL成功实施25例(55.6%),SL但切缘阳性8例,需全肺切除12例。
诊断标准与关键数值
- salvage支气管肿瘤累及长度≤5 mm为SL无残留病变可切除性的最佳截断值,AUC为0.802。
- logistic回归中该特征为唯一显著预测因素,OR 16.0(95%CI 3.7-69.6,P<0.001)。
临床应用与阅片要点
- 术前CT测量 salvage支气管肿瘤累及长度,≤5 mm提示SL无残留病变可切除可能性较高。
- SL无残留病变组术后并发症率20.0%,SL有残留病变或全肺切除组25.0%,两组相似。
- SL无残留病变组生存结局似优于残留病变或全肺切除组(P=0.110),但未达统计学显著。
局限性
- SL无残留病变组与残留病变或全肺切除组生存比较P=0.110,未达统计学显著。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study was to investigate the CT features predictive of resectability in sleeve lobectomy (SL) for patients with non-small cell lung cancers (NSCLCs) and the outcomes of this procedure. MATERIALS AND METHODS. The study included 45 patients with NSCLCs who planned to undergo SL as a first-line surgical option and underwent SL or pneumonectomy between February 2014 and July 2017. The patients were dichotomized according to whether SL was achieved without residual disease. ROC curve and logistic regression analyses were performed to identify CT features predictive of resectability in SL without residual disease. For outcome analysis, postoperative complications and survival were compared between the two patient groups. RESULTS. SL was successfully performed in 25 patients (55.6%), whereas eight patients underwent SL but had a positive resection margin and 12 required pneumonectomy. The AUC value of the tumor-involved length of the salvage bronchus for SL without residual disease was 0.802, with 5 mm considered the optimal cutoff for this tumor-involved length. A tumor-involved length of 5 mm or less for the salvage bronchus representing the distal anastomosis end in SL was the sole significant predictor for resectability in SL without residual disease in logistic regression analysis (odds ratio, 16.0; 95% CI, 3.7-69.6; p < 0.001). The group of patients who underwent SL without residual disease tended to have a more favorable survival outcome than patients who underwent SL but had residual disease or those who underwent pneumonectomy (p = 0.110), but postoperative complication rates were similar between the two patient groups (20.0% vs 25.0%, respectively). CONCLUSION. A tumor-involved salvage bronchus length of 5 mm or less was a CT feature predictive of resectability in SL without residual disease, which may improve the survival of patients with NSCLCs.
引用
- Lee JH, Yoon SH, Kim YT, et al. Sleeve Lobectomy for Non-Small Cell Lung Cancers: Predictive CT Features for Resectability and Outcome Analysis. AJR Am J Roentgenol. 2019. PMID: 31166766. doi:10.2214/AJR.19.21258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。